Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for Biologic Hernia Grafts was estimated to be worth US$ 191 million in 2025 and is projected to reach US$ 249 million, growing at a CAGR of 3.9% from 2026 to 2032.
Biologic hernia grafts are made from animal or human tissue and are used to repair hernias by reinforcing the abdominal wall. These grafts promote natural tissue integration and healing, reducing the risk of infection and complications often associated with synthetic meshes.
Biologic Hernia Grafts Market Size(US$)
M= millions and B=billions

The North American market for Biologic Hernia Grafts was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Biologic Hernia Grafts was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Biologic Hernia Grafts was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Biologic Hernia Grafts market include BD, B. Braun, Cook Medical, Johnson & Johnson, Gore Medical, Medtronic, Allergan, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Biologic Hernia Grafts, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Biologic Hernia Grafts market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Biologic Hernia Grafts.
Market Segmentation
Report Metric
Details
Report Title
Biologic Hernia Grafts - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Forecasted Market Size in 2032
US$ 249 million
CAGR(2026-2032)
3.9%
Market Size Available for Years
2026-2032
Global Biologic Hernia Grafts Companies Covered
BD
B. Braun
Cook Medical
Johnson & Johnson
Gore Medical
Medtronic
Allergan
Global Biologic Hernia Grafts Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biologic Hernia Grafts Market, Segment by Type
Human Sources
Animal Sources
Global Biologic Hernia Grafts Market, Segment by Application
TEP
TAPP
IPOM
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Biologic Hernia Grafts companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Biologic Hernia Grafts revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Biologic Hernia Grafts revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Biologic Hernia Grafts Product Introduction
1.2 Global Biologic Hernia Grafts Market Size Forecast (2021–2032)
1.3 Biologic Hernia Grafts Market Trends & Drivers
1.3.1 Biologic Hernia Grafts Industry Trends
1.3.2 Biologic Hernia Grafts Market Drivers & Opportunities
1.3.3 Biologic Hernia Grafts Market Challenges
1.3.4 Biologic Hernia Grafts Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biologic Hernia Grafts Players Revenue Ranking (2025)
2.2 Global Biologic Hernia Grafts Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Biologic Hernia Grafts Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Biologic Hernia Grafts
2.6 Biologic Hernia Grafts Market Competitive Analysis
2.6.1 Biologic Hernia Grafts Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Biologic Hernia Grafts Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Biologic Hernia Grafts revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Biologic Hernia Grafts Market Classification
3.1 Introduction by Type
3.1.1 Human Sources
3.1.2 Animal Sources
3.1.3 Global Biologic Hernia Grafts Sales Value by Type
3.1.3.1 Global Biologic Hernia Grafts Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Biologic Hernia Grafts Sales Value, by Type (2021–2032)
3.1.3.3 Global Biologic Hernia Grafts Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 TEP
4.1.2 TAPP
4.1.3 IPOM
4.2 Global Biologic Hernia Grafts Sales Value by Application
4.2.1 Global Biologic Hernia Grafts Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Biologic Hernia Grafts Sales Value by Application (2021–2032)
4.2.3 Global Biologic Hernia Grafts Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Biologic Hernia Grafts Sales Value by Region
5.1.1 Global Biologic Hernia Grafts Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Biologic Hernia Grafts Sales Value by Region (2021–2026)
5.1.3 Global Biologic Hernia Grafts Sales Value by Region (2027–2032)
5.1.4 Global Biologic Hernia Grafts Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Biologic Hernia Grafts Sales Value, 2021–2032
5.2.2 North America Biologic Hernia Grafts Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Biologic Hernia Grafts Sales Value, 2021–2032
5.3.2 Europe Biologic Hernia Grafts Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Biologic Hernia Grafts Sales Value, 2021–2032
5.4.2 Asia Pacific Biologic Hernia Grafts Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Biologic Hernia Grafts Sales Value, 2021–2032
5.5.2 South America Biologic Hernia Grafts Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biologic Hernia Grafts Sales Value, 2021–2032
5.6.2 Middle East & Africa Biologic Hernia Grafts Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biologic Hernia Grafts Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Biologic Hernia Grafts Sales Value, 2021–2032
6.3 United States
6.3.1 United States Biologic Hernia Grafts Sales Value, 2021–2032
6.3.2 United States Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Biologic Hernia Grafts Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Biologic Hernia Grafts Sales Value, 2021–2032
6.4.2 Europe Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Biologic Hernia Grafts Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Biologic Hernia Grafts Sales Value, 2021–2032
6.5.2 China Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
6.5.3 China Biologic Hernia Grafts Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Biologic Hernia Grafts Sales Value, 2021–2032
6.6.2 Japan Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Biologic Hernia Grafts Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Biologic Hernia Grafts Sales Value, 2021–2032
6.7.2 South Korea Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Biologic Hernia Grafts Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Biologic Hernia Grafts Sales Value, 2021–2032
6.8.2 Southeast Asia Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Biologic Hernia Grafts Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Biologic Hernia Grafts Sales Value, 2021–2032
6.9.2 India Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
6.9.3 India Biologic Hernia Grafts Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 BD
7.1.1 BD Profile
7.1.2 BD Main Business
7.1.3 BD Biologic Hernia Grafts Products, Services, and Solutions
7.1.4 BD Biologic Hernia Grafts Revenue (US$ Million), 2021–2026
7.1.5 BD Recent Developments
7.2 B. Braun
7.2.1 B. Braun Profile
7.2.2 B. Braun Main Business
7.2.3 B. Braun Biologic Hernia Grafts Products, Services, and Solutions
7.2.4 B. Braun Biologic Hernia Grafts Revenue (US$ Million), 2021–2026
7.2.5 B. Braun Recent Developments
7.3 Cook Medical
7.3.1 Cook Medical Profile
7.3.2 Cook Medical Main Business
7.3.3 Cook Medical Biologic Hernia Grafts Products, Services, and Solutions
7.3.4 Cook Medical Biologic Hernia Grafts Revenue (US$ Million), 2021–2026
7.3.5 Cook Medical Recent Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Profile
7.4.2 Johnson & Johnson Main Business
7.4.3 Johnson & Johnson Biologic Hernia Grafts Products, Services, and Solutions
7.4.4 Johnson & Johnson Biologic Hernia Grafts Revenue (US$ Million), 2021–2026
7.4.5 Johnson & Johnson Recent Developments
7.5 Gore Medical
7.5.1 Gore Medical Profile
7.5.2 Gore Medical Main Business
7.5.3 Gore Medical Biologic Hernia Grafts Products, Services, and Solutions
7.5.4 Gore Medical Biologic Hernia Grafts Revenue (US$ Million), 2021–2026
7.5.5 Gore Medical Recent Developments
7.6 Medtronic
7.6.1 Medtronic Profile
7.6.2 Medtronic Main Business
7.6.3 Medtronic Biologic Hernia Grafts Products, Services, and Solutions
7.6.4 Medtronic Biologic Hernia Grafts Revenue (US$ Million), 2021–2026
7.6.5 Medtronic Recent Developments
7.7 Allergan
7.7.1 Allergan Profile
7.7.2 Allergan Main Business
7.7.3 Allergan Biologic Hernia Grafts Products, Services, and Solutions
7.7.4 Allergan Biologic Hernia Grafts Revenue (US$ Million), 2021–2026
7.7.5 Allergan Recent Developments
8 Industry Chain Analysis
8.1 Biologic Hernia Grafts Value Chain
8.2 Biologic Hernia Grafts Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Biologic Hernia Grafts Sales Model
8.5.2 Sales Channels
8.5.3 Biologic Hernia Grafts Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Biologic Hernia Grafts Market Trends
Table 2. Biologic Hernia Grafts Market Drivers & Opportunities
Table 3. Biologic Hernia Grafts Market Challenges
Table 4. Biologic Hernia Grafts Market Restraints
Table 5. Global Biologic Hernia Grafts Revenue by Company (US$ Million), 2021–2026
Table 6. Global Biologic Hernia Grafts Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies Biologic Hernia Grafts Product Type
Table 9. Key Companies General Availability (GA) Timeline for Biologic Hernia Grafts
Table 10. Global Biologic Hernia Grafts Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Biologic Hernia Grafts revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global Biologic Hernia Grafts Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global Biologic Hernia Grafts Sales Value by Type (US$ Million), 2021–2026
Table 15. Global Biologic Hernia Grafts Sales Value by Type (US$ Million), 2027–2032
Table 16. Global Biologic Hernia Grafts Sales Market Share in Value by Type (2021–2026)
Table 17. Global Biologic Hernia Grafts Sales Market Share in Value by Type (2027–2032)
Table 18. Global Biologic Hernia Grafts Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Biologic Hernia Grafts Sales Value by Application (US$ Million), 2021–2026
Table 20. Global Biologic Hernia Grafts Sales Value by Application (US$ Million), 2027–2032
Table 21. Global Biologic Hernia Grafts Sales Market Share in Value by Application (2021–2026)
Table 22. Global Biologic Hernia Grafts Sales Market Share in Value by Application (2027–2032)
Table 23. Global Biologic Hernia Grafts Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 24. Global Biologic Hernia Grafts Sales Value by Region (US$ Million), 2021–2026
Table 25. Global Biologic Hernia Grafts Sales Value by Region (US$ Million), 2027–2032
Table 26. Global Biologic Hernia Grafts Sales Value by Region (%), 2021–2026
Table 27. Global Biologic Hernia Grafts Sales Value by Region (%), 2027–2032
Table 28. Key Countries/Regions Biologic Hernia Grafts Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 29. Key Countries/Regions Biologic Hernia Grafts Sales Value, (US$ Million), 2021–2026
Table 30. Key Countries/Regions Biologic Hernia Grafts Sales Value, (US$ Million), 2027–2032
Table 31. BD Basic Information List
Table 32. BD Description and Business Overview
Table 33. BD Biologic Hernia Grafts Products, Services, and Solutions
Table 34. Revenue (US$ Million) in Biologic Hernia Grafts Business of BD (2021–2026)
Table 35. BD Recent Developments
Table 36. B. Braun Basic Information List
Table 37. B. Braun Description and Business Overview
Table 38. B. Braun Biologic Hernia Grafts Products, Services, and Solutions
Table 39. Revenue (US$ Million) in Biologic Hernia Grafts Business of B. Braun (2021–2026)
Table 40. B. Braun Recent Developments
Table 41. Cook Medical Basic Information List
Table 42. Cook Medical Description and Business Overview
Table 43. Cook Medical Biologic Hernia Grafts Products, Services, and Solutions
Table 44. Revenue (US$ Million) in Biologic Hernia Grafts Business of Cook Medical (2021–2026)
Table 45. Cook Medical Recent Developments
Table 46. Johnson & Johnson Basic Information List
Table 47. Johnson & Johnson Description and Business Overview
Table 48. Johnson & Johnson Biologic Hernia Grafts Products, Services, and Solutions
Table 49. Revenue (US$ Million) in Biologic Hernia Grafts Business of Johnson & Johnson (2021–2026)
Table 50. Johnson & Johnson Recent Developments
Table 51. Gore Medical Basic Information List
Table 52. Gore Medical Description and Business Overview
Table 53. Gore Medical Biologic Hernia Grafts Products, Services, and Solutions
Table 54. Revenue (US$ Million) in Biologic Hernia Grafts Business of Gore Medical (2021–2026)
Table 55. Gore Medical Recent Developments
Table 56. Medtronic Basic Information List
Table 57. Medtronic Description and Business Overview
Table 58. Medtronic Biologic Hernia Grafts Products, Services, and Solutions
Table 59. Revenue (US$ Million) in Biologic Hernia Grafts Business of Medtronic (2021–2026)
Table 60. Medtronic Recent Developments
Table 61. Allergan Basic Information List
Table 62. Allergan Description and Business Overview
Table 63. Allergan Biologic Hernia Grafts Products, Services, and Solutions
Table 64. Revenue (US$ Million) in Biologic Hernia Grafts Business of Allergan (2021–2026)
Table 65. Allergan Recent Developments
Table 66. Revenue (US$ Million) in Biologic Hernia Grafts Business of Company 40 (2021–2026)
Table 67. Company 40 Recent Developments
Table 68. Key Raw Materials Lists
Table 69. Key Suppliers of Raw Materials Lists
Table 70. Biologic Hernia Grafts Downstream Customers
Table 71. Biologic Hernia Grafts Distributors List
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologic Hernia Grafts Product Picture
Figure 2. Global Biologic Hernia Grafts Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 4. Biologic Hernia Grafts Report Years Considered
Figure 5. Global Biologic Hernia Grafts Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Biologic Hernia Grafts Revenue in 2025
Figure 7. Biologic Hernia Grafts Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. Human Sources Picture
Figure 9. Animal Sources Picture
Figure 10. Global Biologic Hernia Grafts Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Biologic Hernia Grafts Sales Value Market Share by Type, 2025 & 2032
Figure 12. Product Picture of TEP
Figure 13. Product Picture of TAPP
Figure 14. Product Picture of IPOM
Figure 15. Global Biologic Hernia Grafts Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Biologic Hernia Grafts Sales Value Market Share by Application, 2025 & 2032
Figure 17. North America Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 18. North America Biologic Hernia Grafts Sales Value by Country (%), 2025 vs 2032
Figure 19. Europe Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 20. Europe Biologic Hernia Grafts Sales Value by Country (%), 2025 vs 2032
Figure 21. Asia Pacific Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 22. Asia Pacific Biologic Hernia Grafts Sales Value by Subregion (%), 2025 vs 2032
Figure 23. South America Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 24. South America Biologic Hernia Grafts Sales Value by Country (%), 2025 vs 2032
Figure 25. Middle East & Africa Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 26. Middle East & Africa Biologic Hernia Grafts Sales Value by Country (%), 2025 vs 2032
Figure 27. Key Countries/Regions Biologic Hernia Grafts Sales Value (%), 2021–2032
Figure 28. United States Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 29. United States Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
Figure 30. United States Biologic Hernia Grafts Sales Value by Application (%), 2025 vs 2032
Figure 31. Europe Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 32. Europe Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
Figure 33. Europe Biologic Hernia Grafts Sales Value by Application (%), 2025 vs 2032
Figure 34. China Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 35. China Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
Figure 36. China Biologic Hernia Grafts Sales Value by Application (%), 2025 vs 2032
Figure 37. Japan Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 38. Japan Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
Figure 39. Japan Biologic Hernia Grafts Sales Value by Application (%), 2025 vs 2032
Figure 40. South Korea Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 41. South Korea Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
Figure 42. South Korea Biologic Hernia Grafts Sales Value by Application (%), 2025 vs 2032
Figure 43. Southeast Asia Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 44. Southeast Asia Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
Figure 45. Southeast Asia Biologic Hernia Grafts Sales Value by Application (%), 2025 vs 2032
Figure 46. India Biologic Hernia Grafts Sales Value (US$ Million), 2021–2032
Figure 47. India Biologic Hernia Grafts Sales Value by Type (%), 2025 vs 2032
Figure 48. India Biologic Hernia Grafts Sales Value by Application (%), 2025 vs 2032
Figure 49. Biologic Hernia Grafts Value Chain
Figure 50. Biologic Hernia Grafts Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives InterviewedDescription
The global market for Biologic Hernia Grafts was estimated to be worth US$ 191 million in 2025 and is projected to reach US$ 249 million, growing at a CAGR of 3.9% from 2026 to 2032.
Biologic hernia grafts are made from animal or human tissue and are used to repair hernias by reinforcing the abdominal wall. These grafts promote natural tissue integration and healing, reducing the risk of infection and complications often associated with synthetic meshes.
The North American market for Biologic Hernia Grafts was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Biologic Hernia Grafts was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Biologic Hernia Grafts was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Biologic Hernia Grafts market include BD, B. Braun, Cook Medical, Johnson & Johnson, Gore Medical, Medtronic, Allergan, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Biologic Hernia Grafts, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Biologic Hernia Grafts market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Biologic Hernia Grafts.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Biologic Hernia Grafts companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Biologic Hernia Grafts revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Biologic Hernia Grafts revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Reports
The global market for Biologic Hernia Grafts was estimated to be worth US$ 189 million in 2024 and is forecast to a readjusted size of US$ 240 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-02-09
Pages: 99
USD 3950.00
(Single User License)
The global market for Biologic Hernia Grafts was valued at US$ 189 million in the year 2024 and is projected to reach a revised size of US$ 240 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published: 2025-02-09
Pages: 73
USD 2900.00
(Single User License)
The global Biologic Hernia Grafts market size was US$ 189 million in 2024 and is forecast to a readjusted size of US$ 240 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-02-09
Pages: 76
USD 4250.00
(Single User License)
The global Biologic Hernia Grafts market was valued at US$ 191 million in 2025 and is anticipated to reach US$ 249 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-03-11
Pages: 107
USD 2900.00
(Single User License)
The global Biologic Hernia Grafts market size was US$ 191 million in 2025 and is forecast to reach a readjusted size of US$ 249 million by 2032 with a CAGR of 3.9% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 80
USD 4250.00
(Single User License)
The global Biologic Hernia Grafts market is projected to grow from US$ 191 million in 2025 to US$ 249 million by 2032, at a CAGR of 3.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 126
USD 4900.00
(Single User License)
The global market for Biologic Hernia Grafts was estimated to be worth US$ 189 million in 2024 and is forecast to a readjusted size of US$ 240 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-02-09
Pages: 99
The global market for Biologic Hernia Grafts was valued at US$ 189 million in the year 2024 and is projected to reach a revised size of US$ 240 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published: 2025-02-09
Pages: 73
The global Biologic Hernia Grafts market size was US$ 189 million in 2024 and is forecast to a readjusted size of US$ 240 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-02-09
Pages: 76
The global Biologic Hernia Grafts market was valued at US$ 191 million in 2025 and is anticipated to reach US$ 249 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-03-11
Pages: 107
The global Biologic Hernia Grafts market size was US$ 191 million in 2025 and is forecast to reach a readjusted size of US$ 249 million by 2032 with a CAGR of 3.9% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 80
The global Biologic Hernia Grafts market is projected to grow from US$ 191 million in 2025 to US$ 249 million by 2032, at a CAGR of 3.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 126
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database